Evidence map›Paper›PMID 41982438›Full record

ArticleJournal of the Medical Library Association : JMLA2026

Evaluating automated or artificial intelligence search tools for evidence synthesis.

Robin Featherstone

Abstract read
In one paragraph

Article in Journal of the Medical Library Association : JMLA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Robin Featherstonerobin.featherstone@cda-amc.ca, Acting Director, Research Information Services, Canada's Drug Agency, Ottawa, Ontario.ORCID https://orcid.org/0000-0003-2517-2258

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To advance information retrieval science for producing evidence syntheses at Canada's Drug Agency, the Research Information Services team developed a replicable process to evaluate automated or artificial intelligence (AI) search tools. The team inventoried 51 tools in the fall of 2023 and built a flexible evaluation instrument to inform adoption decisions and enable comparison between tools. Building on this foundational evaluation work, the team further conducted a comparative analysis on three top-ranked tools in the fall of 2024. The investigation confirmed that these automated or AI tools have inconsistent and variable performance for the range of information retrieval tasks performed by Information Specialists at Canada's Drug Agency. Implementation recommendations from this study informed a "fit for purpose" approach where Information Specialists leverage automated or AI search tools for specific tasks or project types.

Indexed as

Artificial IntelligenceAutomationInformation Storage and RetrievalCanadaHumansArtificial IntelligenceAutomationGenerative Artificial IntelligenceInformation SciencesInformation Storage and RetrievalLarge Language ModelsReview Literature as Topic

Identifiers

PMID41982438
PMCPMC13075584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.